Saturday, November 14, is World Diabetes Day which begs the question, “What exactly are we celebrating?”
Not to rain on anyone’s parade but diabetes continues to grow at epidemic rates, we are no closer to a cure than we were last year at this time and a strong case can be made that in some respects we’ve gone backwards rather than forward. This is not to say that progress has not been made or m that there have been no positive strides made.
Given that I focus on the business aspects of diabetes, I find little comfort that from a business perspective things are any better. Take a look at the year to date performance for companies who play in this wacky world.
Sanofi (SNY) down 5.59%
MannKind (MNKD) down
52.90%
Insulet (PODD) down 27.99%
AstraZeneca (AZN) down 11.96%
Medtronic (MDT) up 3.48%
Lilly (LLY) up 15.86%
Recommended by Forbes
No comments:
Post a Comment